Lataa...
Efficacy And Safety of Dabigatran Etexilate Utilization With Concomitant Dual Antiplatelet Therapy In Atrial Fibrillation
The necessity to add two antiplatelet agents to an oral anticoagulant (OAC) often arises in patients with atrial fibrillation (AF) in routine clinical practice. The majority of AF patients have an indication for continuous OAC, and coronary artery disease co-exists in 25% of these patients. The incr...
Tallennettuna:
| Julkaisussa: | J Atr Fibrillation |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Cardiofront, Inc
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4956134/ https://ncbi.nlm.nih.gov/pubmed/27957046 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4022/jafib.1001 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|